Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed Apr 8, 2025 · 10-K · 98 days after period end · 0001091818-25-000036
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$123.16K | -$114.41K | -$114.74K | -$120.70K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 8, 2025 · 98 d after period end